But C/EBPβ overexpression and the valsartan treatment ameliorated the diabetes‐induced reduction in MMP‐2 levels, and MMP‐2 was expressed at much higher levels in the C/EBPβ overexpression group than in the valsartan group. Here, CEBPB is linked to diabetes mellitus.